|
|
|
CfPA - The Center for Professional Advancement, 90 Minute Accredited Online Training
May 17, 2011 at 11:00 a.m.–12:30 p.m. (ET)
Who Should Attend Professionals in the drug development industry who specialize in skin applications, either topically or transdermal from the following fields:
• Research and Development • Production • QC/QA • Marketing • Product Development • Formulations Development Description With the rise in recurring skin disorders, skin infectious diseases and chronic systemic disorders such as type two diabetes, and pain associated with aging diseases, the Pharmaceutical industry is challenged to develop delivery systems that will address these needs, be more efficacious, trigger minimum adverse effects and elevate patient compliance.
This 90-minute accredited training course is tailored to provide a review of the newest approaches in the area of topical and transdermal drug delivery to the different applications listed in the outline. This training will include opportunities for learning assessment.
Module 1: • Review of Learning Objectives • Systems for topical delivery 1: – Wound healing – Burns – Infectious diseases
Module 2: • Systems for topical delivery 2: – Pain relief – Chronic skin diseases
Module 3: • Transdermal delivery- new patches technologies • Microneedls • Iontophoresis and Sonophoresis • Semi solids
Summary
Question and Answer Session
|
|
|
|
|
|
Organized by:
|
|
CfPA - The Center for Professional Advancement |
|
Invited Speakers:
|
|
Dr. Nava Dayan, Skin Care Research Expert
Dr. Nava Dayan earned her Ph.D. in Pharmaceutics from the Hebrew University in Jerusalem specializing in skin delivery. She is currently an Associate Adjunct Professor in the Ernest Mario School of Pharmacy at Rutgers University, and the R&D Director at Lipo Chemicals Inc. During her 23 years of experience she has specialized in a variety of areas related to skin treatment:
• The research and understanding of the interaction between topically applied compounds and the skin • Findings in skin biochemistry and especially the upper layer of the skin- the stratum corneum • Delivery of active compounds into and through the skin and the development of delivery systems to facilitate transport, improve bio-availability and reduce toxicity • Design and development of topically applied formulations • Design of clinical studies to substantiate market claims and to assure safety • Academic teaching and lecturing • Industrial experience in both development of active compounds, delivery systems and finished formulations • Skin absorption studies in vivo and in vitro for safety/ efficacy assessment • In vitro methodologies for safety assessment of topically applied compounds
Dr. Dayan has received numerous awards of excellence for various papers she has authored. She is the author and coauthor of more than 100 publications including book chapters and was granted 7 patents. She is also the editor of the “Skin Aging Hand Book” published by Elsevier. Dr. Dayan is a member of the Dermatopharmaceutics Focus Group, and the Abstract Review Committee for the American Association of Pharmaceutical Scientists (AAPS). She is serves as the Educational Chair of the NYSCC Chapter and on the Scientific Advisory Board of Health Beauty America Expo. Dr. Dayan teaches at Rutgers University and is the Director of a variety of courses at the Center for Professional Advancement.
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
E-mail:
|
|
sberg@cfpa.com
|
|
|
|
|
|
|
|